PATENT CLAIM ANALYSIS

Application Number: 16014231
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "259300"]

Abstract:
Compounds of Formula 0, Formula I, and Formula II and methods of use as Interleukin-1 Receptor Associated Kinase (IRAK4) inhibitors are described herein.

Claim (Index 4):
The compound of  claim 1 , or a stereoisomer or pharmaceutically acceptable salt thereof, wherein R 1  and R 4  are each hydrogen, and R 3  is hydrogen, OH, halogen, CH 3 , CH 2 OH, CH 2 F, OCHF 2 , CHF 2 , CF 3 , cyclopropyl, azetidinyl, CN, \u2014C(O)CH 3 , \u2014C(O)NH 2 , \u2014C(O)NHCH 3 , \u2014NHCH 3 , \u2014SO 2 \u2014NH 2 , or \u2014SO 2 \u2014NHCH 3 .

Metadata:
- Claim Count in Document: 17.0
- Percentile: 94.0
- Lexical Diversity: 1.21739
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15905524', '15305390', '15247429', '15822493', '15305372']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8207139103215545
- 35 USC 102 Novelty (BERT): 0.5517324449375807
- Combined Prediction Score: 0.7938157637831571
- Mean Citation Score: 404.523194
- Max Citation Score: 418.23807
- Similarity Product: 343.49028899625955

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test